Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: A revelation by parallel gene expression profiling

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4228-4232

  Fuller, Gregory N ^a   Rhee, Chang Hun ^a,b   Hess, Kenneth R ^a   Caskey, Laura S ^a   Wang, Ruoping ^a   Bruner, Janet M ^a   Yung, W K Alfred ^a   Zhang, Wei ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Korea Cancer Center Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; SOMATOMEDIN BINDING PROTEIN 2;

ADVANCED CANCER; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIOBLASTOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; RNA, MESSENGER;

EID: 0345240919     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. DeRisi, J., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y., Su, Y. A., and Trent, J. M. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet., 14: 457-460, 1996.
2. Lockhart, D. J., Dong, H., Byme, M. C., Follettie, M. T., Gallo, M. V., Chee, M. S., Mittmann, M., Wang, C., Kobayashi, M., Horton, H., and Brown, E. L. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol., 14: 1675-1680, 1996.
3. Service, R. F. Microchip arrays put DNA on the spot. Science (Washington DC), 282: 396-399, 1998.
4. Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (Washington DC), 270: 467-470, 1995.
5. Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. Serial analysis of gene expression. Science (Washington DC), 270: 484-487, 1995.
6. Gammeltoft, S., Ballotti, R., Nielsen, F. C., Kowalski, A., and Van Obberghen, E. Receptors for insulin-like growth factors in the central nervous system: structure and function. Horm. Metab. Res., 20: 436-442, 1998.
7. Glick, R. P., Unterman, T. G., Van der Woude, M., and Blaydes, L. Z. Insulin and insulin-like growth factors in central nervous system tumors. J. Neurosurg., 77: 445-450, 1992.
8. Sandberg-Nordqvist, A. C., Stahlbom, P. A., Reinecke, M., Collins, V. P., von Holst, H., and Sara, V. S. Characterization of insulin-like growth factor I in human primary brain tumors. Cancer Res., 53: 2475-2478, 1993.
9. Morford, L. A., Boghaert, E. R., Brooks, W. H., and Roszman, T. L. Insulin-like growth factors (IGF) enhance three-dimensional (3D) growth of human glioblastomas. Cancer Lett., 115: 81-90, 1997.
10. Jones, J. I., and Clemmons, D. R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 16: 3-34, 1995.
11. Ranke, M. B., and Elmlinger, M. Functional role of insulin-like growth factor binding proteins. Horm. Res., 48: 9-15, 1997.
12. Zapf, J. Physiological role of the insulin-like growth factor binding proteins. Eur. J. Endocrinol., 132: 645-654, 1995.
13. Blum, W. F., Jenne, E. W., Reppin, F., Kietzmann, K., Ranke, M. B., and Bierich, J. R. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology, 125: 766-772, 1989.
14. Bourner, M. J., Busby, W. H., Jr., Siegel, N. R., Krivi, G. G., McCusker, R. H., and Clemmons, D. R. Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-I. J. Cell. Biochem., 48: 215-226, 1992.
15. De Mellow, J. S., and Baxter, R. C. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun., 156: 199-204, 1988.
16. Elgin, R. G., Busby, W. H., Jr., and Clemmons, D. R. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc. Natl. Acad. Sci. USA, 84: 3254-3258, 1987.
17. Cerro, J. A., Grewal, A., and Wood, T. L. Tissue-specific expression of the insulin-like growth factor binding protein (IGFBP) mRNAs in mouse and rat development. Regul. Peptides, 48: 189-198, 1993.
18. Green, B. N., Jones, S. B., Streck, R. D., Wood, T. L., Rotwein, P., and Pintar, J. E. Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. Endocrinology, 134: 954-962, 1994.
19. Lee, W. H., Michels, K. M., and Bondy, C. A. Localization of insulin growth factor binding protein-2 messenger RNA during postnatal brain development: correlation with insulin-like growth factors I and II. Neuroscience, 53: 251-265, 1993.
20. Wood, T. L., Streck, R. D., and Pintar, J. E. Expression of the IGFBP-2 gene in post-implantation rat embryos. Development (Camb.), 114: 59-66, 1992.
21. Cohen, P., Peehl, D. M., Stamey, T. A., Wilson, K. F., Clemmons, D. R., and Rosenfeld, R. G. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J. Clin. Endocrinol. Metab., 76: 1031-1035, 1993.
22. Ho, P. J., and Baxter, R. C. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin. Endocrinol., 46: 333-342, 1997.
23. Kanety, H., Madjar, Y., Dagan, Y., Levi, J., Papa, M. Z., Pariente, C., Goldwasser, B., and Karasik, A. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J. Clin. Endocrinol. Metab., 77: 229-233, 1993.
24. Kanety, H., Kattan, M., Goldberg, I., Kopolovic, J., Ravia, J., Menczer, J., and Karasik, A. Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid. Br. J. Cancer, 73: 1069-1073, 1996.
25. Karasik, A., Menczer, J., Pariente, C., and Kanety, H. Insulin-like growth factor I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J. Clin. Endocrinol. Metab., 78: 271-276, 1994.
26. Menouny, M., Binoux, M., and Babajko, S. IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity. Int. J. Cancer, 77: 874-879, 1998.
27. Daumas-Dupport, C., Scheithauer, B. W., and O'Fallon, J. Grading of astrocytomas. A simple and reproducible method. Cancer (Phila.), 62: 2152-2165, 1998.
28. Shaw, E. G., Scheithauer, B. W., O'Fallon, J. R., and Davis, D. H. Oligodendrogliomas: The Mayo Clinic experience. J. Neurosurg., 76: 428-434, 1992.
29. Kobayashi, T., Ruan, S., Jabbur, J. R., Consoli, U., Clodi, K., Shiku, H., Owen-Schaub, L. B., Andreeff, M., Reed, J. C., and Zhang, W. Differential p53 phosphorylation and activation of apoptosis-promoting genes Box and Fas/APO-I by irradiation and ara-C treatment. Cell Death Differ., 5: 584-591, 1998.
30. Rhee, C. H., Hess, K., Jabbur, J., Ruiz, M., Yang, Y., Chen, S., Chenchik, A., Fuller, G. N., and Zhang, W. cDNA expression array reveals heterogenous gene expression profiles in three glioblastoma cell lines. Oncogene, 18: 2711-2718, 1999.
31. Chan, A. S., Leung, S. Y., and Wong, M. P. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. Am. J. Surg. Pathol., 22: 816-826, 1998.
32. Van Meir, E. G., Kikuchi, T., Tada, M., Li, H., Diserens, A. C., Wojcik. B. E., Huang, H. J., Friedmann, T., de Tribolet, N., and Cavenee, W. K. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res., 54: 649-652, 1994.
33. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., and Schlessinger, J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature (Lond.), 313: 144-147, 1985.
34. Morrison, R. S., Gross, J. L., Herblin, W. F., Reilly, T. M., LaSala, P. A., Alterman, R. L., Moskal, J. R., Kornblith, P. L., and Dexter, D. L. Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res., 50: 2524-2529, 1990.
35. Wrann, M., Bodmer, S., de Martin, R., Siepl, C., Hofer-Warbinek, R., Frei, K., Hofer, E., and Fontana, A. T cell suppressor factor from human glioblastoma cells is a 12.5-kD protein closely related to transforming growth factor-β. EMBO J., 6: 1633-1636, 1987.
36. Nishikawa, R., Furnari, F. B., Lin, H., Arap, W., Berger, M. S., Cavenee, W. K., and Su Huang, H. J. Loss of P16INK4 expression is frequent in high grade gliomas. Cancer Res., 55: 1941-1945, 1995.
37. Paleologos, N. A., and Cairncross, J. G. Treatment of oligodendroglioma: an update. Neuro-Oncology, 1: 61-69, 1999.